About Albila
Albila is a company based in Sisli (Turkey) founded in 2017. Albila offers products and services including Scorpion Anti-venom. Albila operates in a competitive market with competitors including Beijing Kangchen Pharmaceutical, Ophirex, Vins Bio Products, Mediclone Biotech and Mithros Bioscience, among others.
- Headquarter Sisli, Turkey
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Albila Serum Biyolojik Ürünler San. Ve Tic. A.Ş.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Albila
Albila offers a comprehensive portfolio of products and services, including Scorpion Anti-venom.
Serum for treating scorpion stings and venom effects
Funding Insights of Albila
Detailed funding history for Albila
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Albila
Investment portfolio details for Albila
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Albila
Detailed financials for Albila
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Albila Comparisons
Peer comparison for Albila
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Albila
Albila operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beijing Kangchen Pharmaceutical, Ophirex, Vins Bio Products, Mediclone Biotech and Mithros Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antivenom drugs and pharmaceutical products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Oral therapies for snake bite treatment are developed.
|
|
| Locked | Locked | Locked |
Antisera and antitoxins for snake bites and infections are developed.
|
|
| Locked | Locked | Locked |
Diagnostic kits and therapeutic biologics are manufactured and developed.
|
|
| Locked | Locked | Locked |
Develops anti-venom antibodies for medical applications.
|
|
| Locked | Locked | Locked |
Develops recombinant humanized antibodies targeted against snake venom.
|
Detailed competitors of Albila
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Albila
Complete news archive for Albila
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Albila
Albila was founded in 2017.
Albila is headquartered in Sisli, Turkey. It is registered at Sisli, Istanbul, Turkey.
Albila was established in 2017 in Sisli, Turkey, within the biotechnology sector focused on animal health. Antidotes against stings and bites are produced through hyperimmunization of healthy horses. Key products include Scorpion Antiserum, Snake Antiserum, and Rabies Antitoxin, which are formulated to neutralize toxins from scorpions, snakes, and rabies exposure. Operations center on equine-based serum extraction and purification for veterinary and potential human applications.
Albila's top competitors include Ophirex, Beijing Kangchen Pharmaceutical and Vins Bio Products.
Albila offers Scorpion Anti-venom.